Review Article
Impact of Peripheral Nerve Block Technique on Incidence of Phrenic Nerve Palsy in Shoulder Surgery
Table 1
Summary of data from studies of the effect of modifications of the ISB on HDP incidence (n = 13).
| Study | Approach | n | Local anaesthetic | Guidance | Total HDP incidence (%) | Type | Volume (mL) | Concentration (%) |
| Urmey and Gloeggler [72] | Lateral | 10 | Mepivacaine | 20.0 | 1.50 | Landmark (Winnie) | 100.0 | Lateral | 10 | Mepivacaine | 45.0 | 1.50 | Landmark (Winnie) | 100.0 |
| Riazi et al. [73] | Lateral | 20 | Ropivacaine | 5.0 | 0.50 | US, NS | 45.0 | Lateral | 20 | Ropivacaine | 20.0 | 0.50 | US, NS | 100.0 |
| Renes et al. [41] | Lateral | 15 | Ropivacaine | 10.0 | 0.75 | US | 13.3 | Meier | 15 | Ropivacaine | 10.0 | 0.75 | NS | 93.3 |
| Lee et al. [74] | Lateral | 30 | Ropivacaine | 5.0 | 0.75 | US | 33.0 | Lateral | 30 | Ropivacaine | 10.0 | 0.75 | US | 60.0 |
| Sinha et al. [75] | Lateral | 15 | Ropivacaine | 10.0 | 0.50 | US | 93.3 | Lateral | 15 | Ropivacaine | 20.0 | 0.50 | US | 93.3 |
| Wong et al. [76] | Lateral | 23 | Ropivacaine | 20.0 | 0.10 | US, NS | 34.8 | Lateral | 24 | Ropivacaine | 20.0 | 0.20 | US, NS | 66.7 |
| Jadon et al. [77] | Lateral | 50 | Ropivacaine | 30.0 | 0.50 | NS | 16.0 | Lateral | 50 | Ropivacaine (+8 mg dexamethasone) | 30.0 | 0.50 | NS | 20.0 |
| Palhais et al. [30] | Lateral | 20 | Bupivacaine | 20.0 | 0.50 | US | 90.0 | Extrafascial | 19 | Bupivacaine | 20.0 | 0.50 | US | 21.0 |
| Zhai et al. [78] | Lateral | 30 | Ropivacaine | 10.0 | 0.50 | US | 66.7 | Lateral | 30 | Ropivacaine | 20.0 | 0.25 | US | 70.0 |
| Zhai et al. [79] | Lateral | 33 | Ropivacaine | 6.7 | 0.75 | US, NS | 58.0 | Lateral | 29 | Ropivacaine | 10.0 | 0.50 | US, NS | 69.0 | Lateral | 33 | Ropivacaine | 20.0 | 0.25 | US, NS | 70.0 |
| Meena et al. [80] | Lateral | 35 | Ropivacaine | 10.0 | 0.50 | NS | 100.0 | Lateral | 35 | Ropivacaine | 20.0 | 0.50 | NS | 100.0 |
| Ayyanagouda [44] | Extrafascial | 30 | Ropivacaine | 20.0 | 0.50 | US, NS | 17.0 | Lateral | 30 | Ropivacaine | 20.0 | 0.50 | US, NS | 46.0 |
| Kim et al. [35] | Lateral 2-point | 26 | Ropivacaine | 10.0 | 0.50 | US | 53.8 | Lateral 2-point | 26 | Ropivacaine | 15.0 | 0.50 | US | 92.3 |
|
|
US, ultrasound; NS, nerve stimulator.
|